BGIM
HAE icon

Brandywine Global Investment Management’s Haemonetics HAE Stock Holding History

Brandywine Global Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11
Closed -$1K – 743
2022
Q1 		$1K Sell
11
-33,191
-100% -$1.8M ﹤0.01% 712
2021
Q4 		$1.76M Sell
33,202
-397,817
-92% -$24.2M 0.01% 539
2021
Q3 		$30.4M Buy
431,019
+91,964
+27% +$5.8M 0.23% 122
2021
Q2 		$22.6M Buy
+339,055
New +$24M 0.17% 150

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brandywine Global Investment Management's HAE Position: Q2 2022 in Review

Brandywine Global Investment Management sold out of Haemonetics (HAE) in Q2 2022, closing a stake of 11 shares — an estimated $1K sold.

Brandywine Global Investment Management first reported a position in HAE in Q2 2021 and held it in 4 quarters. The position peaked at $30.4M in Q3 2021. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

  • Brandywine Global Investment Management reported no remaining Haemonetics position as of Q2 2022 after selling out during the quarter.
  • Brandywine Global Investment Management sold 11 Haemonetics shares in Q2 2022, an estimated $1K.
  • Brandywine Global Investment Management first reported a position in Haemonetics in Q2 2021 and held it in 4 quarters.
  • Brandywine Global Investment Management's Haemonetics position peaked at $30.4M in Q3 2021.
  • 241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Brandywine Global Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.